On Thursday, Bluebird Bio Inc. (NASDAQ:BLUE) reported a third-quarter EPS loss of 31 cents, compared to a loss of 80 cents a ...

(BLUE) stock downgraded by Bank of America and J.P. Morgan after the company's Q3 2024 results. Read more here.

On Thursday, bluebird bio Inc (BLUE) stock saw a decline, ending the day at $0.36 which represents a decrease of $-0.02 or -5.26% from the prior close of $0.38. The stock opened at $0.37 and touched a ...

In celebration of its 100th year as an institution open to the public, the Morgan Library and Museum has launched the ...

JP Morgan Chase analysts say they’re ‘not surprised’ sector has come ‘under pressure’ since Kennedy’s nomination ...

JP Morgan has recently reduced bluebird bio Inc (BLUE) stock to Neutral rating, as announced on August 15, 2024, according to Finviz. Earlier, on December 11, 2023, HSBC Securities had reduced the ...

J.P. Morgan analyst Eric Joseph maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report) yesterday and set a price ...

(Reuters) -Shares in European vaccine makers fell on Friday after U.S. President-elect Donald Trump picked Robert F. Kennedy ...

Shares in global vaccine makers and drugmakers fell on Friday after U.S. President-elect Donald Trump picked Robert F.

J.P. Morgan analyst Eric Joseph maintained a Sell rating on Novavax ... Joseph covers the Healthcare sector, focusing on stocks such as Bluebird Bio, Wave Life Sciences, and Novavax. TipRanks tracks ...